Insider Trading & Ownership - KALA BIO Inc. (KALA)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for KALA BIO Inc.
Goto Prev, 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2022-05-26
Sale		 2022-05-26
5:09 pm		 Kala Pharmaceuticals Inc. KALA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner		 1,005,686 $0.3636 $365,667 7,039,613
(Indirect)		 View
2022-05-23
Sale		 2022-05-25
5:17 pm		 Kala Pharmaceuticals Inc. KALA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner		 2,829,314 $0.52622 $1,488,844 8,045,299
(Indirect)		 View
2022-01-04
Sale		 2022-01-05
8:00 pm		 Kala Pharmaceuticals Inc. KALA Reumuth Mary
CHIEF FINANCIAL OFFICER		 2,850 $1.3 $3,705 286,208
(Direct)		 View
2022-01-04
Sale		 2022-01-05
8:00 pm		 Kala Pharmaceuticals Inc. KALA Brazzell Romulus K
SEE REMARKS		 3,504 $1.3 $4,555 526,345
(Direct)		 View
2022-01-04
Sale		 2022-01-05
8:00 pm		 Kala Pharmaceuticals Inc. KALA Bazemore Todd
SEE REMARKS		 3,454 $1.3 $4,490 356,633
(Indirect
Direct)		 View
2022-01-04
Sale		 2022-01-05
8:00 pm		 Kala Pharmaceuticals Inc. KALA Iwicki Mark T
CHIEF EXECUTIVE OFFICER		 9,518 $1.3 $12,373 1,034,158
(Direct)		 View
2022-01-04
Sale		 2022-01-05
8:00 pm		 Kala Pharmaceuticals Inc. KALA Trachtenberg Eric
SEE REMARKS		 2,850 $1.3 $3,705 266,816
(Direct)		 View
2021-10-26
Sale		 2021-10-28
8:06 pm		 Kala Pharmaceuticals Inc. KALA Chen Hongming
CHIEF SCIENTIFIC OFFICER		 30,500 $1.8138 $55,321 204,515
(Direct)		 View
2021-10-26
Sale		 2021-10-28
8:05 pm		 Kala Pharmaceuticals Inc. KALA Trachtenberg Eric
SEE REMARKS		 9,449 $1.8 $17,008 116,666
(Direct)		 View
2021-10-26
Sale		 2021-10-28
8:04 pm		 Kala Pharmaceuticals Inc. KALA Reumuth Mary
CHIEF FINANCIAL OFFICER		 9,449 $1.8 $17,008 136,058
(Direct)		 View
2021-10-26
Sale		 2021-10-28
8:03 pm		 Kala Pharmaceuticals Inc. KALA Bazemore Todd
CHIEF OPERATING OFFICER		 12,544 $1.8 $22,579 122,087
(Indirect
Direct)		 View
2021-10-26
Sale		 2021-10-28
8:02 pm		 Kala Pharmaceuticals Inc. KALA Brazzell Romulus K
CHIEF MEDICAL OFFICER		 12,757 $1.8 $22,963 291,849
(Direct)		 View
2021-10-26
Sale		 2021-10-28
8:01 pm		 Kala Pharmaceuticals Inc. KALA Iwicki Mark T
CHIEF EXECUTIVE OFFICER		 27,598 $1.8 $49,676 268,676
(Direct)		 View
2021-06-29
Sale		 2021-06-30
5:30 pm		 Kala Pharmaceuticals Inc. KALA Chen Hongming
CHIEF SCIENTIFIC OFFICER		 5,548 $5.56 $30,847 235,015
(Direct)		 View
2021-06-28
Sale		 2021-06-29
5:26 pm		 Kala Pharmaceuticals Inc. KALA Chen Hongming
CHIEF SCIENTIFIC OFFICER		 2,452 $5.77 $14,148 240,563
(Direct)		 View
2021-06-28
Sale		 2021-06-29
5:26 pm		 Kala Pharmaceuticals Inc. KALA Brazzell Romulus K
CHIEF MEDICAL OFFICER		 3,034 $5.77 $17,506 300,962
(Direct)		 View
2021-06-28
Sale		 2021-06-29
5:26 pm		 Kala Pharmaceuticals Inc. KALA Trachtenberg Eric
SEE REMARKS		 2,452 $5.77 $14,148 126,115
(Direct)		 View
2021-06-28
Sale		 2021-06-29
5:26 pm		 Kala Pharmaceuticals Inc. KALA Reumuth Mary
CHIEF FINANCIAL OFFICER		 2,452 $5.77 $14,148 145,507
(Direct)		 View
2021-06-28
Sale		 2021-06-29
5:25 pm		 Kala Pharmaceuticals Inc. KALA Bazemore Todd
CHIEF OPERATING OFFICER		 2,911 $5.77 $16,796 134,631
(Indirect
Direct)		 View
2021-06-28
Sale		 2021-06-29
5:25 pm		 Kala Pharmaceuticals Inc. KALA Iwicki Mark T
CHIEF EXECUTIVE OFFICER		 7,586 $5.77 $43,771 296,274
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2022-06-16
Option Award		 2022-06-17
4:45 pm		 N/A
2032-06-15		 Kala Pharmaceuticals Inc. KALA Rosen Howard B
Director		 40,000 $0 40,000
(Direct)		 View
2022-06-16
Option Award		 2022-06-17
4:45 pm		 N/A
2032-06-15		 Kala Pharmaceuticals Inc. KALA Blumenkranz Mark S.
Director		 40,000 $0 40,000
(Direct)		 View
2022-06-16
Option Award		 2022-06-17
4:45 pm		 N/A
2032-06-15		 Kala Pharmaceuticals Inc. KALA PERRY GREGORY D
Director		 40,000 $0 40,000
(Direct)		 View
2022-06-16
Option Award		 2022-06-17
4:45 pm		 N/A
2032-06-15		 Kala Pharmaceuticals Inc. KALA Paull Robert Bradley
Director		 40,000 $0 40,000
(Direct)		 View
2022-06-16
Option Award		 2022-06-17
4:45 pm		 N/A
2032-06-15		 Kala Pharmaceuticals Inc. KALA KOVEN ANDREW I
Director		 50,000 $0 50,000
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
8:00 pm		 N/A
2032-01-03		 Kala Pharmaceuticals Inc. KALA Reumuth Mary
CHIEF FINANCIAL OFFICER		 153,000 $0 286,208
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
8:00 pm		 N/A
2032-01-03		 Kala Pharmaceuticals Inc. KALA Brazzell Romulus K
SEE REMARKS		 238,000 $0 526,345
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
8:00 pm		 N/A
2032-01-03		 Kala Pharmaceuticals Inc. KALA Bazemore Todd
SEE REMARKS		 238,000 $0 356,633
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
8:00 pm		 N/A
2032-01-03		 Kala Pharmaceuticals Inc. KALA Iwicki Mark T
CHIEF EXECUTIVE OFFICER		 775,000 $0 1,034,158
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
8:00 pm		 N/A
2032-01-03		 Kala Pharmaceuticals Inc. KALA Trachtenberg Eric
SEE REMARKS		 153,000 $0 266,816
(Direct)		 View
2021-11-15
Option Award		 2021-11-17
8:02 pm		 N/A
2031-11-14		 Kala Pharmaceuticals Inc. KALA Kharabi Darius
CHIEF BUSINESS OFFICER		 395,657 $0 395,657
(Direct)		 View
2021-11-15
Option Award		 2021-11-17
8:01 pm		 N/A
2031-11-14		 Kala Pharmaceuticals Inc. KALA Blumenkranz Mark S.
Director		 5,383,120 $0 238,730
(Direct)		 View
2021-10-15
Option Award		 2021-10-19
4:08 pm		 N/A
2031-10-14		 Kala Pharmaceuticals Inc. KALA Myers C. Daniel
Director		 42,000 $0 42,000
(Direct)		 View
2021-06-17
Option Award		 2021-06-21
5:31 pm		 N/A
N/A		 Kala Pharmaceuticals Inc. KALA Shah Rajeev M.
Director		 20,000 $0 10,914,613
(Direct)		 View
2021-06-17
Option Award		 2021-06-21
5:31 pm		 N/A
N/A		 Kala Pharmaceuticals Inc. KALA Rosen Howard B
Director		 20,000 $0 53,064
(Direct)		 View
2021-06-17
Option Award		 2021-06-21
5:30 pm		 N/A
N/A		 Kala Pharmaceuticals Inc. KALA PERRY GREGORY D
Director		 20,000 $0 40,000
(Direct)		 View
2021-06-17
Option Award		 2021-06-21
5:30 pm		 N/A
N/A		 Kala Pharmaceuticals Inc. KALA Paull Robert Bradley
Director		 20,000 $0 42,361
(Direct)		 View
2021-06-17
Option Award		 2021-06-21
5:30 pm		 N/A
N/A		 Kala Pharmaceuticals Inc. KALA KOVEN ANDREW I
Director		 25,000 $0 53,000
(Direct)		 View
2021-06-17
Option Award		 2021-06-21
5:30 pm		 N/A
N/A		 Kala Pharmaceuticals Inc. KALA Grunberg Gregory
Director		 20,000 $0 5,451,860
(Direct)		 View
2021-04-01
Other		 2021-04-05
4:31 pm		 N/A
N/A		 Kala Pharmaceuticals Inc. KALA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner		 1,687,709 $6.74 12,282,476
(Indirect)		 View
2021-03-01
Exercise		 2021-03-03
5:01 pm		 N/A
2024-10-02		 Kala Pharmaceuticals Inc. KALA Chen Hongming
Chief Scientific Officer		 9,500 $0 296,751
(Direct)		 View
2021-03-01
Exercise		 2021-03-03
5:01 pm		 N/A
N/A		 Kala Pharmaceuticals Inc. KALA Chen Hongming
Chief Scientific Officer		 9,500 $2.3 296,751
(Direct)		 View
2021-02-25
Exercise		 2021-02-26
5:35 pm		 N/A
2024-10-02		 Kala Pharmaceuticals Inc. KALA Chen Hongming
Chief Scientific Officer		 47,000 $0 296,751
(Direct)		 View
2021-02-25
Exercise		 2021-02-26
5:35 pm		 N/A
N/A		 Kala Pharmaceuticals Inc. KALA Chen Hongming
Chief Scientific Officer		 47,000 $2.3 296,751
(Direct)		 View
Goto Prev, 0, 1, 2, 3, Next